BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31922645)

  • 1. Eyelid edema as first manifestation of anti-MDA5 positive dermatomyositis with rapidly progressive interstitial lung disease: A case report.
    Ludriksone L; Pfeil A; Schliemann S; Elsner P
    J Dtsch Dermatol Ges; 2020 Mar; 18(3):263-265. PubMed ID: 31922645
    [No Abstract]   [Full Text] [Related]  

  • 2. Inverse Gottron's Sign in A Patient With Anti-MDA5 Associated Dermatomyositis With Rapidly Progressive Interstitial Lung Disease.
    Lee HJ; Feng A; Huan NC
    Am J Med Sci; 2021 Oct; 362(4):e35. PubMed ID: 33582154
    [No Abstract]   [Full Text] [Related]  

  • 3. Unilateral Eyelid Swelling as a Sign of Antimelanoma Differentiation-Associated Gene 5 (Anti-MDA5)-Antibody-Positive Dermatomyositis.
    Lam SC; Yuen HKL
    Ophthalmic Plast Reconstr Surg; 2018; 34(6):e209-e211. PubMed ID: 30365479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease - a case report.
    De Backer E; Gremonprez F; Brusselle G; Depuydt P; Van Dorpe J; Van Haverbeke C; Goeminne PC; Derom E
    Acta Clin Belg; 2018 Dec; 73(6):413-417. PubMed ID: 29287518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis.
    Sakamoto S; Okamoto M; Kaieda S; Fujimoto K; Nagata S; Tominaga M; Nakamura M; Zaizen Y; Nouno T; Koga T; Kawayama T; Kuwana M; Ida H; Hoshino T
    Respir Investig; 2018 Nov; 56(6):464-472. PubMed ID: 30150008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
    Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M
    Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis.
    Sakamoto N; Ishimoto H; Nakashima S; Yura H; Miyamura T; Okuno D; Hara A; Kitazaki T; Kakugawa T; Ishimatsu Y; Satoh M; Mukae H
    Intern Med; 2019 Mar; 58(6):837-841. PubMed ID: 30449789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing Time of Onset for Interstitial Lung Disease in Anti-MDA5 Antibody-Positive Dermatomyositis.
    Lin RR; Warp PV; Maderal AD; Elman SA
    JAMA Dermatol; 2024 May; 160(5):575-577. PubMed ID: 38598206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juvenile dermatomyositis associated with anti-melanoma differentiation-associated gene 5 antibody positivity without complications of interstitial lung disease during the clinical course: A case report.
    Koike M; Hayashi S; Okamoto M; Kaminaga T; Hamasaki Y; Igawa K
    J Dermatol; 2019 Sep; 46(9):e308-e309. PubMed ID: 30869164
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dermatomyositis associated with anti-MDA5 autoantibody].
    Collado MV; Gargiulo MLÁ; Gómez R; Gómez G; Pérez N; Suarez L; Taratuto AL; Aruj P
    Medicina (B Aires); 2018; 78(5):360-363. PubMed ID: 30285929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review].
    Hou J; Zhou ZX; Li JG; Xu YJ; Ding YC
    Zhonghua Er Ke Za Zhi; 2019 Dec; 57(12):928-933. PubMed ID: 31795559
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of simultaneous onset of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis accompanied by interstitial pneumonia and pulmonary tuberculosis.
    Fujimoto S; Saito K; Kuwano K
    Int J Rheum Dis; 2020 Feb; 23(2):273-275. PubMed ID: 31916372
    [No Abstract]   [Full Text] [Related]  

  • 13. Case of anti-MDA-5 positive dermatomyositis with rapidly progressive interstitial lung disease.
    Fenando A; Firn K; Louissa S; Hussain A
    BMJ Case Rep; 2020 Apr; 13(4):. PubMed ID: 32354766
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease disguising as anti-synthetase syndrome.
    Tanaka N; Terao C; Nakayama Y; Sasai T; Umezawa N; Yagyu Y; Ito K; Koike R; Nakashima R; Hatta K; Mizoguchi F
    Rheumatology (Oxford); 2021 Mar; 60(3):e104-e106. PubMed ID: 33097938
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical features and poor prognostic factors of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with rapid progressive interstitial lung disease.
    Motegi SI; Sekiguchi A; Toki S; Kishi C; Endo Y; Yasuda M; Ikeuchi H; Sakairi T; Hara K; Yamaguchi K; Maeno T; Hiromura K; Ishikawa O
    Eur J Dermatol; 2019 Oct; 29(5):511-517. PubMed ID: 31617496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful multi-target therapy including rituximab and mycophenolate mofetil in anti-melanoma differentiation-associated gene 5 antibody-positive rapidly progressive interstitial lung disease with clinically amyopathic dermatomyositis.
    Hisanaga J; Kotani T; Fujiki Y; Yoshida S; Takeuchi T; Makino S
    Int J Rheum Dis; 2017 Dec; 20(12):2182-2185. PubMed ID: 28752606
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of anti-MDA5-positive rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis ameliorated by rituximab, in addition to standard immunosuppressive treatment.
    Koichi Y; Aya Y; Megumi U; Shunichi K; Masafumi S; Hiroaki M; Masahiko K; Shinsuke K; Manabu U; Kenichiro H; Fumiaki A; Nozomi A; Toshitaka M; Masayoshi Y; Chikako K; Yoshinao M; Tatsuo S; Masahiko K
    Mod Rheumatol; 2017 May; 27(3):536-540. PubMed ID: 25698373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catch the thief by its marks: inverse Gottron papules, interstitial lung disease, anti MDA-5 antibody positivity in juvenile dermatomyositis.
    Anjani G; Govindarajan S; Sudhakar M; Chaudhary H; Rawat A; Kumar Jindal A
    Rheumatology (Oxford); 2021 Feb; 60(2):e56-e58. PubMed ID: 32888028
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review.
    González-Moreno J; Raya-Cruz M; Losada-Lopez I; Cacheda AP; Oliver C; Colom B
    Rheumatol Int; 2018 Jul; 38(7):1293-1296. PubMed ID: 29417209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 21-Year-Old Woman With Joint Pain and Skin Ulceration.
    French S; Lang UE; Margaretten M
    Arthritis Care Res (Hoboken); 2021 Nov; 73(11):1553-1560. PubMed ID: 31961480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.